Kater AP - Search Results

1

Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia.

Niemann CU, Levin MD, Dubois J, Kersting S, Enggaard L, Veldhuis GJ, Mous R, Mellink CHM, Dobber JA, Poulsen CB, Frederiksen H, Janssens A, Schjødt I, Dompeling EC, Ranti J, Mattsson M, Bellido M, Tran HTT, Nasserinejad K, Kater AP. Niemann CU, et al. Among authors: kater ap. Blood. 2021 Feb 25;137(8):1117-1120. doi: 10.1182/blood.2020008608. Blood. 2021. PMID: 33027809 Free article. Clinical Trial. No abstract available.

2

Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis.

Kater AP, Dicker F, Mangiola M, Welsh K, Houghten R, Ostresh J, Nefzi A, Reed JC, Pinilla C, Kipps TJ. Kater AP, et al. Blood. 2005 Sep 1;106(5):1742-8. doi: 10.1182/blood-2005-02-0695. Epub 2005 May 24. Blood. 2005. PMID: 15914559 Free PMC article.

3

Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity.

Smit LA, Hallaert DY, Spijker R, de Goeij B, Jaspers A, Kater AP, van Oers MH, van Noesel CJ, Eldering E. Smit LA, et al. Among authors: kater ap. Blood. 2007 Feb 15;109(4):1660-8. doi: 10.1182/blood-2006-05-021683. Epub 2006 Oct 12. Blood. 2007. PMID: 17038534 Free article.

4

Cellular immune therapy for chronic lymphocytic leukemia.

Kater AP, van Oers MH, Kipps TJ. Kater AP, et al. Blood. 2007 Oct 15;110(8):2811-8. doi: 10.1182/blood-2007-01-068932. Epub 2007 Jul 16. Blood. 2007. PMID: 17638850 Free article. Review.

5

No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia.

Tonino SH, Spijker R, Luijks DM, van Oers MH, Kater AP. Tonino SH, et al. Among authors: kater ap. Blood. 2008 Aug 1;112(3):840-3. doi: 10.1182/blood-2008-03-144576. Epub 2008 Jun 2. Blood. 2008. PMID: 18519815 Free article.

6

c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches.

Hallaert DY, Jaspers A, van Noesel CJ, van Oers MH, Kater AP, Eldering E. Hallaert DY, et al. Among authors: kater ap. Blood. 2008 Dec 15;112(13):5141-9. doi: 10.1182/blood-2008-03-146704. Epub 2008 Sep 16. Blood. 2008. PMID: 18796631 Free article.

7

miR-34a as part of the resistance network in chronic lymphocytic leukemia.

Zenz T, Mohr J, Eldering E, Kater AP, Bühler A, Kienle D, Winkler D, Dürig J, van Oers MH, Mertens D, Döhner H, Stilgenbauer S. Zenz T, et al. Among authors: kater ap. Blood. 2009 Apr 16;113(16):3801-8. doi: 10.1182/blood-2008-08-172254. Epub 2008 Oct 21. Blood. 2009. PMID: 18941118 Free article.

8

Detection of p53 dysfunction in chronic lymphocytic leukaemia cells through multiplex quantification of p53 target gene induction.

Mous R, Jaspers A, Luijks DM, Mellink CH, van Oers MH, Kater AP, Eldering E. Mous R, et al. Among authors: kater ap. Leukemia. 2009 Jul;23(7):1352-5. doi: 10.1038/leu.2009.71. Epub 2009 Apr 2. Leukemia. 2009. PMID: 19340003 No abstract available.

9

ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia.

Tonino SH, van Laar J, van Oers MH, Wang JY, Eldering E, Kater AP. Tonino SH, et al. Among authors: kater ap. Oncogene. 2011 Feb 10;30(6):701-13. doi: 10.1038/onc.2010.441. Epub 2010 Oct 11. Oncogene. 2011. PMID: 20935673 Free PMC article.

10

The biological rationale and clinical efficacy of inhibition of signaling kinases in chronic lymphocytic leukemia.

de Weerdt I, Eldering E, van Oers MH, Kater AP. de Weerdt I, et al. Among authors: kater ap. Leuk Res. 2013 Jul;37(7):838-47. doi: 10.1016/j.leukres.2013.03.011. Epub 2013 Apr 15. Leuk Res. 2013. PMID: 23597579 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220 results

Search Page